Sign in
4

Changes in Ownership

Can-Fite BioPharma Ltd. Filed Acc 0001213900-26-066290

Options or other derivatives

  • CEO, CFO and COO acquired 24,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Farbstein Motti · CEO, CFO and COO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-04 Grant or award : show line 1 in the form Options to Purchase Ordinary Shares +24,000 33,132 D
Loading xslF345X06/ownership.xml…